News May 23, 2023 University of Basel and RocketVax present new COVID vaccine Researchers from the University of Basel have developed a new concept for a COVID vaccine in collaboration with the biotech start-up RocketVax. I...
Aktuell May 23, 2023 Universität Basel und RocketVax stellen neuen COVID-Impfstoff vor Forschende der Universität Basel haben mit dem Biotech-Start-up RocketVax ein neues Konzept für einen Corona-Impfstoff entwickelt. Er beruht auf ...
News Feb 08, 2023 RocketVax raises fresh capital The biotech start-up RocketVax has successfully closed another financing round. This additional funding will primarily be used to further develop...
News Mar 09, 2020 Breakthrough in coronavirus research at the University of Bern Researchers at the University of Bern have developed a technique to produce synthetic clones of the new coronavirus strain.
Aktuell Feb 08, 2023 RocketVax erhält frisches Kapital Das Biotech-Start-up RocketVax hat eine weitere Finanzierungsrunde erfolgreich abgeschlossen. Die zusätzlichen Mittel fliessen vor allem in die W...
Actualités Mar 09, 2020 Percée dans la recherche sur le coronavirus à l’Université de Berne Des chercheurs de l'Université de Berne ont mis au point une méthode permettant de produire des clones synthétiques du coronavirus.
Actualités Nov 08, 2022 "Difficile de battre la qualité suisse; même les chinois le reconnaissent." UCB Établie en Belgique, UCB est une société biopharmaceutique active à l’international. Depuis 1996, elle a investi plus de 600 millions d...
Aktuell Apr 27, 2023 Schweizer Biotech erzielt 2022 wieder Rekordumsatz Der Schweizer Biotech-Sektor hat 2022 Höchstwerte bei Umsatz, Investitionen und Beschäftigungszahl erreicht. Das zeigt der aktuelle Swiss Biotech...
News Jun 01, 2021 The Spiez Laboratory at the heart of the WHO’s BioHub system The Spiez Laboratory will be the first facility to be part of the WHO’s BioHub system, an infrastructure that will facilitate the timely sharing ...
Success stories May 25, 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
News Apr 26, 2021 Record year for Western Switzerland’s biotech industry Biotechnology companies based in Switzerland have experienced record investments in the pandemic year 2020. The western Switzerland region, home ...
News May 28, 2021 EPFL develops hydrogel that repairs tears in human tissue EPFL scientists have developed an injectable gel that can attach to various kinds of soft internal tissues and repair tears resulting from an acc...
News May 06, 2021 Berna Biotech Pharma and Swiss Biotech Center to develop second-generation covid-19 vaccine Swiss biotech companies Berna Biotech Pharma and Swiss Biotech Center are joining forces to develop a second-generation vaccine against covid-19....
News May 16, 2023 NewBiologix pioneers breakthrough gene therapies with USD 50 million investment NewBiologix, a biotechnology start-up founded by industry veterans Igor Fisch and Nicolas Mermod, has announced a USD 50 million Series A funding...
News Apr 27, 2021 Lonza invests CHF 200 million in a new production facility in Visp Biopharmaceutical company Lonza will build a new manufacturing facility dedicated to small molecules at its site in Visp. The new investment amou...